Factors influencing participation in colorectal cancer screening programs in Spain

Please use this identifier to cite or link to this item: http://hdl.handle.net/10045/69448
Información del item - Informació de l'item - Item information
Title: Factors influencing participation in colorectal cancer screening programs in Spain
Authors: Vanaclocha-Espi, Mercedes | Ibáñez, Josefa | Molina-Barceló, Ana | Pérez, Elena | Nolasco, Andreu | Font, Rebeca | Pérez-Riquelme, Francisco | Vega, Mariola de la | Arana-Arri, Eunate | Oceja, M. Elena | Espinàs, Josep Alfons | Portillo, Isabel | Salas, Dolores | CRIBEA Group
Research Group/s: Grupo Balmis de Investigación en Salud Comunitaria e Historia de la Ciencia
Center, Department or Service: Universidad de Alicante. Departamento de Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia
Keywords: CCR screening | FOBT | Participation
Knowledge Area: Enfermería
Issue Date: 5-Sep-2017
Publisher: Elsevier
Citation: Preventive Medicine. 2017. doi:10.1016/j.ypmed.2017.08.019
Abstract: To analyze the sociodemographic and organizational factors influencing participation in population-based colorectal cancer screening programs (CRCSP) in Spain, a retrospective study was conducted in a cohort of people invited to participate in the first 3 screening rounds of 6 CRCSP from 2000 to 2012. Mixed logistic regression models were used to analyze the relationship between sociodemographic and organizational factors, such as the type of fecal occult blood test (FOBT) used and the FOBT delivery type. The analysis was performed separately in groups (Initial screening-first invitation, Subsequent invitation for previous never-responders, Subsequent invitation-regular, Subsequent invitation-irregular intervals). The results showed that, in the Initial screening-first invitation group, participation was higher in women than in men in all age groups (OR 1.05 in persons aged 50–59 years and OR 1.12 in those aged 60–69 years). Participation was also higher when no action was required to receive the FOBT kit, independently of the type of screening (Initial screening-first invitation [OR 2.24], Subsequent invitation for previous never-responders [OR 2.14], Subsequent invitation-regular [OR 2.03], Subsequent invitation-irregular intervals [OR 9.38]) and when quantitative rather than qualitative immunological FOBT (FIT) was offered (Initial screening-first invitation [OR 0.70], Subsequent invitation for previous never-responders [OR 0.12], Subsequent invitation-regular [OR 0.20]) or guaiac testing (Initial screening-first invitation [OR 0.81], Subsequent invitation for previous never-responders [OR 0.88], Subsequent invitation-regular [OR 0.73]). In conclusion, the results of this study show that screening participation could be enhanced by inclusion of the FOBT kit with the screening invitation and the use of the quantitative FIT.
Sponsor: This Project was funded by the Fondo de Investigación Sanitario with cofunding from FEDER [PI12/00944]
URI: http://hdl.handle.net/10045/69448
ISSN: 0091-7435 (Print) | 1096-0260 (Online)
DOI: 10.1016/j.ypmed.2017.08.019
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2017 Elsevier Inc.
Peer Review: si
Publisher version: http://dx.doi.org/10.1016/j.ypmed.2017.08.019
Appears in Collections:INV - SALUD - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
Thumbnail2017_Vanaclocha-Espi_etal_PreventiveMed_accepted.pdfAccepted Manuscript (acceso abierto)716,9 kBAdobe PDFOpen Preview
Thumbnail2017_Vanaclocha-Espi_etal_PreventiveMed_final.pdfVersión final (acceso restringido)165,32 kBAdobe PDFOpen    Request a copy


Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.